Donaldson DCI · NYSE
$87.27 -0.80% (-$0.70)
Summary
70 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 13 years in a row and pays out only 32% of profit.
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- It earns 14 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 22.5 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it grew by 4.2% a year. For the next fiscal year analysts expect revenue to grow by 7.9%. Earnings per share grew by 9.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 65 USD
- Research and development 2.0 USD
- Sales and administration 17 USD
- Taxes and other 3.8 USD
- Net profit 12 USD
Net profit, industry median (Industrial - Machinery) 7.2 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.41%
- Paid out of profit
- 32%
- Raised in a row
- 13 years
You receive $1.24 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 6
- Sell 3
Today's price within the analysts' price targets
The average target of $96.5 is 11% above today's price. 36% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Mobile Solutions Segment 62%
- Industrial Solutions Segment 29%
- Life Sciences Segment 8.6%
By region
- United States And Canada 43%
- EMEA 29%
- Asia Pacific 18%
- Latin America 11%
Mobile Solutions Segment brings in 62% of revenue. Life Sciences Segment grew fastest, by 4.5% a year.
Segments in detail